Macular thickness and systemic markers for diabetes in individuals with no or mild diabetic retinopathy

Clinical and Experimental Ophthalmology

Volumn 36, Issue 5, 2008, Pages 455-463

  Asefzadeh, Baharak ^a,b   Fisch, Barry M ^a,b   Parenteau, Chad E ^a   Cavallerano, Anthony A ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NEW ENGLAND COLLEGE OF OPTOMETRY   (United States)

Author keywords

Diabeticretinopathy; Macular thickness; Optical coherence tomography; Retina

Indexed keywords

HEMOGLOBIN A1C; INSULIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; DIGITAL IMAGING; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVE DEGENERATION; OPTICAL COHERENCE TOMOGRAPHY; PROSPECTIVE STUDY; RETINA FOVEA; RETINA MACULA LUTEA; SYSTOLIC BLOOD PRESSURE; UNITED STATES;

AGED; BIOLOGICAL MARKERS; BLOOD PRESSURE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; DIABETIC RETINOPATHY; DIAGNOSIS, COMPUTER-ASSISTED; DIAGNOSTIC IMAGING; FEMALE; FOVEA CENTRALIS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MACULA LUTEA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TOMOGRAPHY, OPTICAL COHERENCE; TRIGLYCERIDES;

EID: 50849091917     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2008.01769.x     Document Type: Article

References (54)

1. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IV. Diabetic macular edema. Ophthalmology 1984; 91: 1464-74.
2. Klein BE, Davis MD, Segal P et al. Diabetic retinopathy: Assessment of severity and progression. Ophthalmology 1984; 91: 10-17.
3. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 1984; 102: 527-32.
4. Klein R, Klein BE, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema. Ophthalmology 1995; 102: 7-16.
5. Klein BE, Klein R, Moss SE, Palta M. A cohort study of the relationship of diabetic retinopathy to blood pressure. Arch Ophthalmol 1995; 113: 601-6.
6. Klein BE, Moss SE, Klein R, Surawicz TS. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XIII. Relationship of serum cholesterol to retinopathy and hard exudate. Ophthalmology 1991; 98: 1261-5.
7. Klein R, Klein BE, Moss SE. Relation of glycemic control to diabetic microvascular complications in diabetes mellitus. Ann Intern Med 1996; 124: 90-6.
8. Klein R, Klein BE, Moss SE, Cruickshanks KJ. Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy. Arch Intern Med 1994; 154: 2169-78.
9. Treatment E, Group. Early Treatment R. Diabetic Retinopathy Study research group. Photocoagulation for diabetic macular edema. ETDRS report number 1. Arch Ophthalmol 1985; 103: 1796-806.
10. Lopes de Faria JM, Jalkh AE, Trempe CL, McMeel JW. Diabetic macular edema: Risk factors and concomitants. Acta Ophthalmol Scand 1999; 77: 170-5.
11. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-53.
12. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317: 703-13.
13. Matthews DR, Stratton IM, Aldington SJ, Holman RR, Kohner EM, UK Prospective Diabetes Study Group. Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69. Arch Ophthalmol 2004; 122: 1631-40.
14. Miljanovic B, Glynn RJ, Nathan DM, Manson JE, Schaumberg DA. A prospective study of serum lipids and risk of diabetic macular edema in type 1 diabetes. Diabetes 2004; 53: 2883-92.
15. Kohner EM, Aldington SJ, Stratton IM et al. United Kingdom Prospective Diabetes Study, 30: Diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors. Arch Ophthalmol 1998; 116: 297-303.
16. Tovi J, Ingemansson SO, Engfeldt P. Insulin treatment of elderly type 2 diabetic patients: Effects on retinopathy. Diabetes Metab 1998; 24: 442-7.
17. Diabetes Control and Complications Trial Research Group. Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Ophthalmology 1995; 102: 647-61.
18. Hee MR, Puliafito CA, Wong C et al. Quantitative assessment of macular edema with optical coherence tomography. Arch Ophthalmol 1995; 113: 1019-29.
19. Brown JC, Solomon SD, Bressler SB, Schachat AP, DiBernardo C, Bressler NM. Detection of diabetic foveal edema: Contact lens biomicroscopy compared with optical coherence tomography. Arch Ophthalmol 2004; 122: 330-5.
20. Otani T, Kishi S, Maruyama Y. Patterns of diabetic macular edema with optical coherence tomography. Am J Ophthalmol 1999; 127: 688-93.
21. Lattanzio R, Brancato R, Pierro L et al. Macular thickness measured by optical coherence tomography (OCT) in diabetic patients. Eur J Ophthalmol 2002; 12: 482-7.
22. Sanchez-Tocino H, Alvarez-Vidal A, Maldonado MJ, Moreno-Montanes J, Garcia-Layana A. Retinal thickness study with optical coherence tomography in patients with diabetes. Invest Ophthalmol Vis Sci 2002; 43: 1588-94.
23. Schaudig UH, Glaefke C, Scholz F, Richard G. Optical coherence tomography for retinal thickness measurement in diabetic patients without clinically significant macular edema. Ophthalmic Surg Lasers 2000; 31: 182-6.
24. Massin P, Erginay A, Haouchine B, Mehidi AB, Paques M, Gaudric A. Retinal thickness in healthy and diabetic subjects measured using optical coherence tomography mapping software. Eur J Ophthalmol 2002; 12: 102-8.
25. Alkuraya H, Kangave D, Abu El-Asrar AM. The correlation between optical coherence tomographic features and severity of retinopathy, macular thickness and visual acuity in diabetic macular edema. Int Ophthalmol 2005; 26: 93-9.
26. Early Treatment Diabetic Retinopathy Study Research Group. Fundus photographic risk factors for progression of diabetic retinopathy: ETDRS report number 12. Ophthalmology 1991; 98 (Suppl. 5): 823-33.
27. Cavallerano AA, Cavallerano JD, Katalinic P et al. Joslin Vision Network Research Team. A telemedicine program for diabetic retinopathy in a veterans affairs medical center -the Joslin Vision Network Eye Health Care Model. Am J Ophthalmol 2005; 139: 597-604.
28. Cavallerano JD, Aiello LP, Cavallerano AA et al. Joslin Vision Network Clinical Team. Nonmydriatic digital imaging alternative for annual retinal examination in persons with previously documented no or mild diabetic retinopathy. Am J Ophthalmol 2005; 140: 667-73.
29. Wilkinson CP, Ferris FL 3rd, Klein RE et al., Global Diabetic Retinopathy Project Group. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003; 110: 1677-82.
30. Goebel W, Kretzchmar-Gross T. Retinal thickness in diabetic retinopathy: a study using optical coherence tomography (OCT). Retina 2002; 22: 759-67.
31. Hee MR, Puliafito CA, Duker JS et al. Topography of diabetic macular edema with optical coherence tomography. Ophthalmology 1998; 105: 360-70.
32. Yang CS, Cheng CY, Lee FL, Hsu WM, Liu JH. Quantitative assessment of retinal thickness in diabetic patients with and without clinically significant macular edema using optical coherence tomography. Acta Ophthalmol Scand 2001; 79: 266-70.
33. Han Y, Bearse MA Jr, Schneck ME, Barez S, Jacobsen CH, Adams AJ. Multifocal electroretinogram delays predict sites of subsequent diabetic retinopathy. Invest Ophthalmol Vis Sci 2004; 45: 948-54.
34. Di Leo MA, Falsini B, Caputo S, Ghirlanda G, Porciatti V, Greco AV. Spatial frequency-selective losses with pattern electroretinogram in type 1 (insulin-dependent) diabetic patients without retinopathy. Diabetologia 1990; 33: 726-30.
35. Caputo S, Di Leo MA, Falsini B et al. Evidence for early impairment of macular function with pattern ERG in type I diabetic patients. Diabetes Care 1990; 13: 412-18.
36. Ghirlanda G, Di Leo MA, Caputo S et al. Detection of inner retina dysfunction by steady-state focal electroretinogram pattern and flicker in early IDDM. Diabetes 1991; 40: 1122-7.
37. Fortune B, Schneck ME, Adams AJ. Multifocal electroretinogram delays reveal local retinal dysfunction in early diabetic retinopathy. Invest Ophthalmol Vis Sci 1999; 40: 2638-51.
38. Bearse MA Jr, Han Y, Schneck ME, Adams AJ. Retinal function in normal and diabetic eyes mapped with the slow flash multifocal electroretinogram. Invest Ophthalmol Vis Sci 2004; 45: 296-304.
39. Bearse MA Jr, Han Y, Schneck ME, Barez S, Jacobsen C, Adams AJ. Local multifocal oscillatory potential abnormalities in diabetes and early diabetic retinopathy. Invest Ophthalmol Vis Sci 2004; 45: 3259-65.
40. Yaltkaya K, Balkan S, Baysal AI. Visual evoked potentials in diabetes mellitus. Acta Neurol Scand 1988; 77: 239-41.
41. Mariani E, Moreo G, Colucci GB. Study of visual evoked potentials in diabetics without retinopathy: Correlations with clinical findings and polyneuropathy. Acta Neurol Scand 1990; 81: 337-40.
42. Dosso AA, Bonvin ER, Morel Y, Golay A, Assal JP, Leuenberger PM. Risk factors associated with contrast sensitivity loss in diabetic patients. Graefes Arch Clin Exp Ophthalmol 1996; 234: 300-5.
43. Trick GL, Burde RM, Gordon MO, Santiago JV, Kilo C. The relationship between hue discrimination and contrast sensitivity deficits in patients with diabetes mellitus. Ophthalmology 1988; 95: 693-8.
44. Aizu Y, Oyanagi K, Hu J, Nakagawa H. Degeneration of retinal neuronal processes and pigment epithelium in the early stage of the streptozotocin-diabetic rats. Neuropathology 2002; 22: 161-70.
45. Park SH, Park JW, Park SJ et al. Apoptotic death of photoreceptors in the streptozotocin-induced diabetic rat retina. Diabetologia 2003; 46: 1260-8.
46. Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW. Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest 1998; 102: 783-91.
47. Barber AJ. A new view of diabetic retinopathy: A neurodegenerative disease of the eye. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27: 283-90.
48. Lieth E, Gardner TW, Barber AJ, Antonetti DA, Penn State Retina Research Group. Retinal neurodegeneration: Early pathology in diabetes. Clin Experiment Ophthalmol 2000; 28: 3-8.
49. Sugimoto M, Sasoh M, Ido M, Wakitani Y, Takahashi C, Uji Y. Detection of early diabetic change with optical coherence tomography in type 2 diabetes mellitus patients without retinopathy. Ophthalmologica 2005; 219: 379-85.
50. Massin P, Erginay A, Haouchine B, Mehidi AB, Paques M, Gaudric A. Retinal thickness in healthy and diabetic subjects measured using optical coherence tomography mapping software. Eur J Ophthalmol 2002; 12: 102-8.
51. Chamberlain MD, Guymer RH, Dirani M, Hopper JL, Baird PN. Heritability of macular thickness determined by optical coherence tomography. Invest Ophthalmol Vis Sci 2006; 47: 336-40.
52. Chan A, Duker JS, Ko TH, Fujimoto JG, Schuman JS. Normal macular thickness measurements in healthy eyes using Stratus optical coherence tomography. Arch Ophthalmol 2006; 124: 193-8.
53. Lattanzio R, Brancato R, Pierro L et al. Macular thickness measured by optical coherence tomography (OCT) in diabetic patients. Eur J Ophthalmol 2002; 12: 482-7.
54. Sánchez-Tocino H, Alvarez-Vidal A, Maldonado MJ, Moreno-Montañés J, García-Layana A. Retinal thickness study with optical coherence tomography in patients with diabetes. Invest Ophthalmol Vis Sci 2002; 43: 1588-94.